West German Study Group

This study is for people with early-stage, hormone-sensitive breast cancer who are at a higher risk of the cancer coming back. It will test if starting treatment with a new oral drug called elacestrant (with or without another standard drug) for five years works better than the c…

This large trial aims to find better ways to control early-stage triple-negative breast cancer, an aggressive form of the disease. It will test if a new combination of two drugs (sacituzumab govitecan and pembrolizumab) works better than standard chemotherapy for patients who sti…